Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertensionlabwebsite20170701Jan 7, 20191 min read being held on February 23, 2019 in La Jolla, CA.
Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation.
Comments